Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPPORTUNE trial of GDC-0941 plus anastrozole versus anastrozole alone in estrogen receptor-positive breast cancer
ISRCTN26131497Phase 2Completed
- Sponsor
- Brighton and Sussex University Hospitals NHS Trust
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 2, randomised, open-label trial in breast cancer comparing Anastrozole alone with GDC-0941 + anastrozole (2 arms). Started Jan 2012; status: completed.
02
Drugs
pictilisibanastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on ISRCTN26131497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN26131497.